Cash Flow Statement
Growth Metrics

Orthofix Medical (OFIX) Return on Capital Employed (2016 - 2026)

Orthofix Medical has reported Return on Capital Employed over the past 16 years, most recently at 6.64% for Q1 2026.

  • For the quarter ending Q1 2026, Return on Capital Employed rose 794.0% year-over-year to 6.64%, compared with a TTM value of 6.64% through Mar 2026, up 794.0%, and an annual FY2025 reading of 11.61%, down 18.0% over the prior year.
  • Return on Capital Employed came in at 6.64% for Q1 2026, up from 12.13% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 1.0% in Q4 2022 to a low of 18.54% in Q4 2023.
  • Median Return on Capital Employed over the past 5 years was 12.83% (2024), compared with a mean of 10.61%.
  • The sharpest move saw Return on Capital Employed crashed -1754bps in 2023, then surged 794bps in 2026.
  • Over 5 years, Return on Capital Employed stood at 1.0% in 2022, then tumbled by -1748bps to 18.54% in 2023, then surged by 36bps to 11.89% in 2024, then decreased by -2bps to 12.13% in 2025, then soared by 45bps to 6.64% in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Return on Capital Employed are 6.64% (Q1 2026), 12.13% (Q4 2025), and 13.84% (Q3 2025).